India reports 188 new COVID cases in last 24 hours

India reports 188 new COVID cases in last 24 hours The daily COVID positivity rate stands at 0.14 per cent, whereas the weekly positivity rate stands at 0.18 per cent. The government relayed that the total recovery from coronavirus infections in the last 24 hours is recorded to be 141, bringing the total recovery tally to 4,41,43,483 since the onset of the pandemic, and the recovery rate to 98.8 per cent. https://ift.tt/2dq31TL

What the World Should Really Expect From COVID in 2023

submitted by /u/themimeofthemollies [link] [comments]

source https://www.reddit.com/r/Health/comments/zwt5tx/what_the_world_should_really_expect_from_covid_in/

‘Too much’ nitrite-cured meat brings clear risk of cancer, say scientists

‘Too much’ nitrite-cured meat brings clear risk of cancer, say scientists

submitted by /u/magenta_placenta [link] [comments]

https://ift.tt/STjGon2 December 28, 2022 at 03:57AM https://ift.tt/rdvTHAg

‘Too much’ nitrite-cured meat brings clear risk of cancer, say scientists

submitted by /u/magenta_placenta [link] [comments]

‘This looks like the real deal’: are we inching closer to a treatment for Alzheimer’s? | Health

‘This looks like the real deal’: are we inching closer to a treatment for Alzheimer’s? | Health

submitted by /u/miolmok [link] [comments]

https://ift.tt/DdvUhrV December 27, 2022 at 04:09PM https://ift.tt/NK42mXa

‘This looks like the real deal’: are we inching closer to a treatment for Alzheimer’s? | Health

submitted by /u/miolmok [link] [comments]

Bharat Biotech's iNNOVACC: India's 1st intranasal vaccine to cost Rs 800 in private markets, Rs 325 for govt

Bharat Biotech's iNNOVACC: India's 1st intranasal vaccine to cost Rs 800 in private markets, Rs 325 for govt iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion-stabilized SARS-CoV-2 spike protein. This vaccine candidate was evaluated in phases I, II and III clinical trials with successful results. https://ift.tt/lIYBNH0